Pfizer opens new facility in Dalian

DALIAN: The US-based pharmaceutical giant Pfizer unveiled its new manufacturing facility on Friday in this port city of Northeast China's Liaoning province after 20 years of its presence in China.

"The new manufacturing facility will almost triple the production capacity of cephalosporin vials, an antibiotic used for the treatment of bacterial infections in the Dalian site, meeting rapidly growing demand in China and other markets," Ahmet Esen, country manager of Pfizer China said.

The move is part of Pfizer's strategy to continue to invest in its Dalian site, its first manufacturing facility set up in China in 1989, in a bid to transform it into one of the firm's most important global suppliers, said Allan Gabor, regional president of North Asia, Emerging Market Business Unit of Pfizer.